Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-25-013827
Filing Date
2025-02-04
Accepted
2025-02-04 17:51:35
Documents
1
Period of Report
2025-02-03

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 5814
  Complete submission text file 0000950170-25-013827.txt   7197
Mailing Address 80 GUEST STREET BOSTON MA 02135
Business Address 80 GUEST STREET BOSTON MA 02135 (617)500-8864
Aura Biosciences, Inc. (Issuer) CIK: 0001501796 (see all company filings)

EIN.: 320271970 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 100 SUMMER STREET, SUITE 2300 BOSTON MA 02110
Business Address
Kilroy Conor (Reporting) CIK: 0001808510 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40971 | Film No.: 25589917